Spectral Medical Inc.
EDT.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.73% | -23.36% | 1.90% | -111.90% | -68.58% |
| Total Depreciation and Amortization | 1.71% | 9.14% | 13.36% | -6.91% | -6.39% |
| Total Amortization of Deferred Charges | -180.72% | -81.18% | 286.49% | 9.03% | 927.55% |
| Total Other Non-Cash Items | 63.77% | 69.56% | 5.59% | 983.00% | 1,131.34% |
| Change in Net Operating Assets | -99.70% | -53.04% | 346.42% | 359.24% | 1,664.52% |
| Cash from Operations | -4.15% | -3.95% | 19.12% | 20.78% | 13.92% |
| Capital Expenditure | 98.52% | 94.60% | 85.39% | -572.73% | -823.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.35% | 94.60% | 85.39% | -572.73% | -823.60% |
| Total Debt Issued | -45.36% | 143.89% | 143.89% | -24.60% | 231.14% |
| Total Debt Repaid | 2.14% | -24.41% | -20.47% | -7,966.67% | -45.83% |
| Issuance of Common Stock | -52.57% | 130.63% | -- | -71.78% | -74.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -520.87% | -233.18% | -233.18% | 105.00% | -63.66% |
| Cash from Financing | -64.19% | 45.23% | 60.34% | -35.32% | 52.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | -- |
| Net Change in Cash | -185.98% | 89.89% | 101.44% | -81.96% | 565.57% |